“Deciphera first contracted Wolfe Laboratories to conduct some analytical method development work.  We were so impressed with the quality, timeliness and dedication to the project that we began utilizing Wolfe’s DMPK services as well. They have handled our compound with confidence and it ultimately advanced into animal studies.  Throughout our partnership, the reports have been outstanding and their employees are very responsive to our needs. We will continue partnering with Wolfe Laboratories to carry more candidates through our pipeline."

- Mike Rafferty, Ph.D.
  Chief Operating Officer                                                                    
  Deciphera Pharmaceuticals

“We have a long-standing partnership with Wolfe Laboratories in our drug development process.  When we were faced with very aggressive timelines to acquire additional stability data, Wolfe Laboratories became an extension of Stryker’s formulation team. The communication, flexibility, experience and commitment to excellence we saw from Wolfe Laboratories during this crucial time was beyond our expectation.”

- Bret Shirley, Ph.D.
  Senior Director of Pharmaceutical Science                                     
  Stryker Biotech 

“For Hydra Biosciences, it’s critical that we partner with a discovery and development team we can trust. We trust Wolfe
Laboratories because time after time, they provide the constant feedback and timeliness we need to move our program forward.  Their analytical team offers a new level of responsiveness and expert insight that we simply haven’t found anywhere else and this is why Wolfe has become a key contributor to our preclinical program.  We always know we can count on Wolfe Laboratories to deliver on time, while adhering to the highest standard of quality.”

- Neil Hayward, Ph.D.
  Vice President of Pharmacology & Toxicology                             
  Hydra Biosciences

“Wolfe Laboratories came to CoLucid's rescue during a critical time before a Phase I study when we discovered there was a stability problem with our originally intended drug product. Wolfe's scientific team responded at a moment's notice and developed workable formulations that allowed us to get our clinical trial back on track with minimal delay. In addition, Wolfe's team provided training for our overseas trial personnel on formulation preparation. In every instance, Wolfe's people have been exceptional and possessed the same work ethic and attention to detail that we expect from our own employees. We value their expertise and collaborative spirit.”

- Barry Dussault
  Associate Director of Clinical Operations
  CoLucid Pharmaceuticals, Inc.